2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
3.160
+0.050 (1.61%)
Nov 21, 2024, 4:00 PM EST - Market closed
2seventy bio Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$10.40
Upside
+229.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +89.87% | Jul 29, 2024 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +58.23% | Jun 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +248.10% | May 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +279.75% | Apr 8, 2024 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | +58.23% | Mar 18, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $5 → $18 | Hold → Buy | Upgrades | $5 → $18 | +469.62% | Jan 31, 2024 |
| TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 31, 2024 |
| Wedbush | Wedbush | Buy → Hold Downgrades $2 | Buy → Hold | Downgrades | $2 | -36.71% | Nov 20, 2023 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +311.39% | Oct 12, 2023 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 13, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $5 | Strong Buy → Hold | Downgrades | $5 | +58.23% | Sep 13, 2023 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 12, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $27 → $26 | Strong Buy | Maintains | $27 → $26 | +722.78% | Aug 15, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $24 | Strong Buy | Maintains | $27 → $24 | +659.49% | Aug 15, 2023 |
| Wedbush | Wedbush | Buy Maintains $26 → $22 | Buy | Maintains | $26 → $22 | +596.20% | Jul 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.